細胞毒性薬の世界市場レポート 2025年

細胞毒性薬市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）5.7％で203億米ドルに成長します。予測期間の成長は、個別化医療アプローチの採用、がん専門治療センターの増加、ライフスタイルの変化によるがん罹患率の増加、併用療法に対する需要の高まり、がん治療と研究を支援する政府の取り組みなどに起因すると考えられます。予測期間における主な動向としては、従来の化学療法から標的療法へのシフト、がん治療における生物製剤やバイオシミラーの使用増加、創薬・開発における人工知能の統合、バイオテクノロジー企業と学術機関の共同研究の増加などが挙げられます。

対象疾患の増加は、今後数年間の細胞毒性薬市場の成長を牽引すると予想されます。標的疾患とは、患者の予後を改善することを目的とした集中的な医学研究、治療、介入努力の焦点となっている特定の疾患または状態を指します。対象疾患の例としては、がん、自己免疫疾患、遺伝性疾患などが挙げられます。対象疾患の罹患率増加の要因としては、遺伝的素因、環境要因、ヘルスケアへの不十分なアクセスなどが挙げられます。細胞毒性薬は、疾患の原因となる細胞を死滅させるか成長を阻害することにより、その増殖と拡大を抑制することで、対象疾患の発生増加と闘う上で重要な役割を果たします。例えば、世界保健機関（WHO）のがん専門機関である国際がん研究機関（IARC）が発表したデータによると、2022年には世界で約2,000万人のがん患者が新たに発生し、970万人が死亡しています。予測によれば、2050年までに新規症例は77％増の3,500万人を超えるといいます。特に肺がんと女性の乳がんは、2022年に世界的に最も罹患率が高かったです。したがって、対象疾患の発生が増加していることが、細胞毒性薬市場拡大の原動力となっています。

細胞毒性薬市場の主なプレーヤーは、キメラ抗原受容体（CAR）T細胞療法などの先進的かつ革新的なソリューションを開発し、特定のタイプの血液がん患者に変革的な治療選択肢を提供するための取り組みを強化しています。CAR T細胞療法は、がん細胞と闘うために遺伝子操作されたT細胞を用いる先駆的な治療アプローチであり、がん治療における重要なブレークスルーを示すものです。例えば、2024年3月、ブリストル・マイヤーズスクイブ社は、再発または難治性の慢性リンパ性白血病（CLL）または小リンパ球性リンパ腫（SLL）の成人患者を対象としたCD19指向性CAR T細胞療法であるBreyanziのFDA承認を発表しました。この承認は、CD19指向性CAR T細胞療法による個別化医療の進歩を強調するものであり、患者に新たな治療の道筋と有効性の向上をもたらすものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細胞毒性薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の細胞毒性薬市場：成長率分析
• 世界の細胞毒性薬市場の実績：規模と成長, 2019-2024
• 世界の細胞毒性薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界細胞毒性薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細胞毒性薬市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルキル化剤
• 抗腫瘍抗生物質
• 代謝拮抗剤
• 植物アルカロイド
• その他の薬物の種類
• 世界の細胞毒性薬市場セラピーによって、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 放射線療法
• 免疫療法
• 幹細胞移植
• その他の治療法
• 世界の細胞毒性薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 関節リウマチ
• 多発性硬化症
• その他の用途
• 世界の細胞毒性薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• がん研究センター
• 薬物検査研究所
• 契約開発製造組織（CDMO）
• 世界の細胞毒性薬市場アルキル化剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 窒素マスタード
• エチレンイミン
• アルキルスルホン酸塩
• トリアゼン
• 世界の細胞毒性薬市場抗腫瘍抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アントラサイクリン
• ブレオマイシン
• マイトマイシン
• 世界の細胞毒性薬市場代謝拮抗剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトトレキサート
• 5-フルオロウラシル
• プリン類似体
• 世界の細胞毒性薬市場植物アルカロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビンカアルカロイド
• タキサン
• カンプトテシン類似体
• 世界の細胞毒性薬市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 白金系化合物
• 抗体薬物複合体（ADC）
• ニトロソウレア

第7章 地域別・国別分析

• 世界の細胞毒性薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細胞毒性薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞毒性薬市場：競合情勢
• 細胞毒性薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Fresenius Kabi AG
• GlaxoSmithKline Plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Merck KGaA
• Evonik Industries AG
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Daiichi Sankyo Company Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細胞毒性薬市場2029：新たな機会を提供する国
• 細胞毒性薬市場2029：新たな機会を提供するセグメント
• 細胞毒性薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cytotoxic drugs constitute a class of medications designed to halt or eradicate rapidly proliferating cells, particularly cancer cells, by impeding their growth and division. They accomplish this by disrupting various biological processes, including metabolism, mitosis, and DNA replication. These drugs are frequently administered in conjunction with other therapeutic modalities such as surgery, radiation therapy, and targeted therapies to maximize treatment effectiveness and better manage cancer.

The primary types of cytotoxic drugs include alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. Alkylating agents, for instance, are utilized in cancer treatment to induce DNA damage in cancer cells, thus inhibiting their ability to multiply. These drugs find application across various therapies such as chemotherapy, radiotherapy, immunotherapy, and stem cell transplantation, addressing conditions such as oncology, rheumatoid arthritis, multiple sclerosis, among others. They are utilized by a diverse range of end users including hospitals, cancer research centers, drug testing laboratories, and contract development and manufacturing organizations (CDMOs).

The cytotoxic drugs market research report is one of a series of new reports from The Business Research Company that provides cytotoxic drugs market statistics, including cytotoxic drugs industry global market size, regional shares, competitors with a cytotoxic drugs market share, detailed cytotoxic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the cytotoxic drugs industry. This cytotoxic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cytotoxic drugs market size has grown strongly in recent years. It will grow from $15.35 billion in 2024 to $16.27 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in the prevalence of cancer globally, the increase in healthcare expenditure, the growth of the aging population, the availability of government funding and grants, and the increased public awareness about cancer treatments.

The cytotoxic drugs market size is expected to see strong growth in the next few years. It will grow to $20.3 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the adoption of personalized medicine approaches, growth in the number of specialized cancer treatment centers, increasing incidence of cancer due to lifestyle changes, rising demand for combination therapies, and government initiatives supporting cancer treatment and research. Major trends in the forecast period include a shift towards targeted therapies over traditional chemotherapy, increasing use of biologics and biosimilars in cancer treatment, integration of artificial intelligence in drug discovery and development, and rise in collaborations between biotech firms and academic institutions.

The rising occurrence of target diseases is expected to drive the growth of the cytotoxic drugs market in the coming years. Target diseases refer to specific illnesses or conditions that are the focus of concentrated medical research, treatment, or intervention efforts aimed at improving patient outcomes. Examples of target diseases include cancer, autoimmune disorders, genetic conditions, and others. Factors contributing to the increased incidence of target diseases include genetic predisposition, environmental factors, and inadequate access to healthcare. Cytotoxic drugs play a crucial role in combating the increased occurrence of target diseases by either killing or inhibiting the growth of disease-causing cells, thereby curbing their proliferation and spread. For example, data published by the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO), revealed approximately 20 million new cancer cases and 9.7 million deaths worldwide in 2022. Projections suggest a staggering 77% increase to over 35 million new cases by 2050. Notably, lung cancer and female breast cancer were the most prevalent globally in 2022. Hence, the heightened occurrence of target diseases is a driving force behind the expansion of the cytotoxic drugs market.

Key players in the cytotoxic drugs market are intensifying their efforts to develop advanced and innovative solutions, such as chimeric antigen receptor (CAR) T cell therapies, to offer transformative treatment options for patients with specific types of blood cancer. CAR T cell therapy represents a pioneering treatment approach that employs genetically engineered T cells to combat cancer cells, marking a significant breakthrough in oncology therapeutics. For instance, in March 2024, Bristol Myers Squibb announced FDA approval of Breyanzi, a CD19-directed CAR T cell therapy for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This approval underscores the advancements in personalized medicine through CD19-directed CAR T cell therapy, providing new treatment avenues and improved efficacy for patients.

In March 2024, Johnson & Johnson acquired Ambrx Biopharma Inc. for approximately $2.0 billion, enhancing its oncology portfolio and prostate cancer innovation by leveraging Ambrx's advanced ADC (antibody-drug conjugate) technology. This technology combines specific monoclonal antibodies with potent chemotherapeutic payloads, augmenting Johnson & Johnson's capabilities in manufacturing cytotoxic drugs. Ambrx Biopharma Inc., a clinical-stage biopharmaceutical company based in the US, specializes in the development of cytotoxic drugs.

Major companies operating in the cytotoxic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Fresenius Kabi AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Merck KGaA, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Daiichi Sankyo Company Limited, Lonza, Eisai Co. Ltd., Sun Pharmaceuticals, Sumitomo Dainippon Pharma, Jazz Pharma, Ipsen Pharma, Kyowa Kirin Co. Ltd., Cipla Ltd., Mallinckrodt Pharmaceuticals, Hansoh Pharmaceutical Group Company Limited, Piramal Group

North America was the largest region in the cytotoxic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cytotoxic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cytotoxic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cytotoxic drugs market consists of sales of monoclonal antibodies, tyrosine kinase inhibitors, topoisomerase inhibitors, platinum-based drugs, proteasome inhibitors, and angiogenesis inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cytotoxic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cytotoxic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cytotoxic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cytotoxic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Alkylating Agents; Antitumor Antibiotics; Antimetabolites; Plant Alkaloids; Other Drug Types
• 2) By Therapy: Chemotherapy; Radiotherapy; Immunotherapy; Stem Cell Transplantation; Other Therapies
• 3) By Application: Oncology; Rheumatoid Arthritis; Multiple Sclerosis; Other Applications
• 4) By End User: Hospitals; Cancer Research Centers; Drug Testing Laboratories; Contract Development And Manufacturing Organizations (CDMOs)
• Subsegments:
• 1) By Alkylating Agents: Nitrogen Mustards; Ethyleneimines; Alkyl Sulfonates; Triazenes
• 2) By Antitumor Antibiotics: Anthracyclines; Bleomycin; Mitomycin
• 3) By Antimetabolites: Methotrexate; 5-Fluorouracil; Purine Analogs
• 4) By Plant Alkaloids: Vinca Alkaloids; Taxanes; Camptothecin Analogs
• 5) By Other Drug Types: Platinum-Based Compounds; Antibody-Drug Conjugates (ADCs); Nitrosoureas
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Roche Holding AG; Merck & Co.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cytotoxic Drugs Market Characteristics

3. Cytotoxic Drugs Market Trends And Strategies

4. Cytotoxic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cytotoxic Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cytotoxic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cytotoxic Drugs Market Growth Rate Analysis
• 5.4. Global Cytotoxic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cytotoxic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cytotoxic Drugs Total Addressable Market (TAM)

6. Cytotoxic Drugs Market Segmentation

• 6.1. Global Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antitumor Antibiotics
• Antimetabolites
• Plant Alkaloids
• Other Drug Types
• 6.2. Global Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Stem Cell Transplantation
• Other Therapies
• 6.3. Global Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Rheumatoid Arthritis
• Multiple Sclerosis
• Other Applications
• 6.4. Global Cytotoxic Drugs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Cancer Research Centers
• Drug Testing Laboratories
• Contract Development And Manufacturing Organizations (CDMOs)
• 6.5. Global Cytotoxic Drugs Market, Sub-Segmentation Of Alkylating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nitrogen Mustards
• Ethyleneimines
• Alkyl Sulfonates
• Triazenes
• 6.6. Global Cytotoxic Drugs Market, Sub-Segmentation Of Antitumor Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anthracyclines
• Bleomycin
• Mitomycin
• 6.7. Global Cytotoxic Drugs Market, Sub-Segmentation Of Antimetabolites, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Methotrexate
• 5-Fluorouracil
• Purine Analogs
• 6.8. Global Cytotoxic Drugs Market, Sub-Segmentation Of Plant Alkaloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vinca Alkaloids
• Taxanes
• Camptothecin Analogs
• 6.9. Global Cytotoxic Drugs Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Platinum-Based Compounds
• Antibody-Drug Conjugates (ADCs)
• Nitrosoureas

7. Cytotoxic Drugs Market Regional And Country Analysis

• 7.1. Global Cytotoxic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cytotoxic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cytotoxic Drugs Market

• 8.1. Asia-Pacific Cytotoxic Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cytotoxic Drugs Market

• 9.1. China Cytotoxic Drugs Market Overview
• 9.2. China Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cytotoxic Drugs Market

• 10.1. India Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cytotoxic Drugs Market

• 11.1. Japan Cytotoxic Drugs Market Overview
• 11.2. Japan Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cytotoxic Drugs Market

• 12.1. Australia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cytotoxic Drugs Market

• 13.1. Indonesia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cytotoxic Drugs Market

• 14.1. South Korea Cytotoxic Drugs Market Overview
• 14.2. South Korea Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cytotoxic Drugs Market

• 15.1. Western Europe Cytotoxic Drugs Market Overview
• 15.2. Western Europe Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cytotoxic Drugs Market

• 16.1. UK Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cytotoxic Drugs Market

• 17.1. Germany Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cytotoxic Drugs Market

• 18.1. France Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cytotoxic Drugs Market

• 19.1. Italy Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cytotoxic Drugs Market

• 20.1. Spain Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cytotoxic Drugs Market

• 21.1. Eastern Europe Cytotoxic Drugs Market Overview
• 21.2. Eastern Europe Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cytotoxic Drugs Market

• 22.1. Russia Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cytotoxic Drugs Market

• 23.1. North America Cytotoxic Drugs Market Overview
• 23.2. North America Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cytotoxic Drugs Market

• 24.1. USA Cytotoxic Drugs Market Overview
• 24.2. USA Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cytotoxic Drugs Market

• 25.1. Canada Cytotoxic Drugs Market Overview
• 25.2. Canada Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cytotoxic Drugs Market

• 26.1. South America Cytotoxic Drugs Market Overview
• 26.2. South America Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cytotoxic Drugs Market

• 27.1. Brazil Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cytotoxic Drugs Market

• 28.1. Middle East Cytotoxic Drugs Market Overview
• 28.2. Middle East Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cytotoxic Drugs Market

• 29.1. Africa Cytotoxic Drugs Market Overview
• 29.2. Africa Cytotoxic Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cytotoxic Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cytotoxic Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cytotoxic Drugs Market Competitive Landscape And Company Profiles

• 30.1. Cytotoxic Drugs Market Competitive Landscape
• 30.2. Cytotoxic Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cytotoxic Drugs Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca plc
• 31.5. Fresenius Kabi AG
• 31.6. GlaxoSmithKline Plc
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. Amgen Inc.
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Merck KGaA
• 31.12. Evonik Industries AG
• 31.13. Teva Pharmaceutical Industries Ltd.
• 31.14. Baxter International Inc.
• 31.15. Daiichi Sankyo Company Limited

32. Global Cytotoxic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cytotoxic Drugs Market

34. Recent Developments In The Cytotoxic Drugs Market

35. Cytotoxic Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Cytotoxic Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cytotoxic Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cytotoxic Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer